Amylyx’s Relyvrio/Albrioza Launch Chugs Along As Firm Gives EU Another Go

 
• By Alaric DeArment
  
Amylyx announced its Q2 earnings, including an update on the launch of its ALS drug Relyvrio/Albrioza • Source: Shutterstock

More from Earnings

More from Business